武汉云克隆科技股份有限公司

尿激酶型纤溶酶原激活因子受体(uPAR)单克隆抗体(异硫氰酸荧光素标记)

FITC-Linked Monoclonal Antibody to Plasminogen Activator, Urokinase Receptor (uPAR)

CD87; PLAUR; PLAU-R; U-PAR; URKR; Monocyte Activation Antigen Mo3

  • 尿激酶型纤溶酶原激活因子受体(uPAR)单克隆抗体(异硫氰酸荧光素标记)产品包装(模拟)
  • 尿激酶型纤溶酶原激活因子受体(uPAR)单克隆抗体(异硫氰酸荧光素标记)产品包装(模拟)
  • Certificate通过ISO 9001、ISO 13485质量体系认证

特异性

该抗体是针对uPAR的小鼠单克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别uPAR。

用法

免疫印迹：0.2-2µg/mL;1:500-5000
免疫组织化学：5-20µg/mL;1:50-200
免疫细胞化学：5-20µg/mL;1:50-200
最佳稀释倍数最终由用户决定。

储存

经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。

赠品

相关产品

编号适用物种：Homo sapiens (Human，人)应用(仅供研究使用，不用于临床诊断！)
RPA141Hu01尿激酶型纤溶酶原激活因子受体(uPAR)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPA141Hu02尿激酶型纤溶酶原激活因子受体(uPAR)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
APA141Hu04尿激酶型纤溶酶原激活因子受体(uPAR)活性蛋白Cell culture; Activity Assays.
RPA141Hu04尿激酶型纤溶酶原激活因子受体(uPAR)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPA141Hu03尿激酶型纤溶酶原激活因子受体(uPAR)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAA141Hu04尿激酶型纤溶酶原激活因子受体(uPAR)多克隆抗体WB
PAA141Hu01尿激酶型纤溶酶原激活因子受体(uPAR)多克隆抗体WB; IHC
PAA141Hu02尿激酶型纤溶酶原激活因子受体(uPAR)多克隆抗体WB
PAA141Hu03尿激酶型纤溶酶原激活因子受体(uPAR)多克隆抗体WB; IHC; ICC; IP.
LAA141Hu71尿激酶型纤溶酶原激活因子受体(uPAR)多克隆抗体(生物素标记)WB; IHC; ICC.
LAA141Hu83尿激酶型纤溶酶原激活因子受体(uPAR)多克隆抗体(异硫氰酸荧光素标记)WB; IHC; ICC; IF.
LAA141Hu81尿激酶型纤溶酶原激活因子受体(uPAR)多克隆抗体(异硫氰酸荧光素标记)WB; IHC; ICC; IF.
FAA141Hu81抗尿激酶型纤溶酶原激活因子受体(uPAR)多克隆抗体(异硫氰酸荧光素标记)FCM
MAA141Hu22尿激酶型纤溶酶原激活因子受体(uPAR)单克隆抗体WB; IHC; ICC; IP.
MAA141Hu21尿激酶型纤溶酶原激活因子受体(uPAR)单克隆抗体WB; IHC; ICC; IP.
LAA141Hu82尿激酶型纤溶酶原激活因子受体(uPAR)单克隆抗体(异硫氰酸荧光素标记)WB; IHC; ICC; IF.
SEA141Hu尿激酶型纤溶酶原激活因子受体(uPAR)检测试剂盒(酶联免疫吸附试验法)Enzyme-linked immunosorbent assay for Antigen Detection.
LMA141Hu尿激酶型纤溶酶原激活因子受体(uPAR)等多因子检测试剂盒(流式荧光发光法)FLIA Kit for Antigen Detection.

参考文献

杂志参考文献
International Journal of CancerDietary supplementation with methylseleninic acid, but not selenomethionine, reduces spontaneous metastasis of Lewis lung carcinoma in mice[Wiley: source]
Biomark Insights Decreased Epidermal Growth Factor (EGF) Associated with HMGB1 and Increased Hyperactivity in Children with Autism[PubMed: PMC3623607]
Biomarker insightsDecreased Hepatocyte Growth Factor (HGF) and Gamma Aminobutyric Acid (GABA) in Individuals with Obsessive-Compulsive Disorder (OCD)[PubMed: PMC3762604]
Am J Emerg MedClinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic guidance of sepsis[PubMed: 26615223]
Archives of Clinical Infectious DiseasesEvaluation of Diagnostic Value of Soluble Urokinase-Type Plasminogen Activator Receptor in Sepsis[Archcid: 26346]
The American Journal of Emergency Medicine Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic Cavia (Guinea pig )idance of sepsis[science:S0735675715009559]
Journal of Clinical and Experimental HepatologyEvaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) …[10.1016:j.jceh.2018.02.001]
Turkish journal of trauma & emergency surgeryThe diagnostic value of serum urokinase-type plasminogen activator receptor in acute appendicitis[Pubmed: 31475329]
CELL TRANSPLANTATIONPredictive Value of Degranulating Factors of Neutrophils in Massive Cerebral Infarction[33787356]